Cite

    Contreras, J. A., Lin, A. J., Weiner, A., Speirs, C., Samson, P., Mullen, D., Campian, J., Bradley, J., Roach, M., & Robinson, C. (2018). cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer. Radiotherapy and oncology, 128(3), 498–504. http://access.bl.uk/ark:/81055/vdc_100067954295.0x000058